Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1988/001448external-prioritypatent/WO1988008306A1/en
Application filed by Gen Hospital CorpfiledCriticalGen Hospital Corp
Publication of DK544789D0publicationCriticalpatent/DK544789D0/en
Publication of DK544789ApublicationCriticalpatent/DK544789A/en
Application grantedgrantedCritical
Publication of DK173137B1publicationCriticalpatent/DK173137B1/en
Process for changing the concentration, or the degree of expression, of a desired gene product in a recipient individual, which process involves administering, to a recipient, a transkaryotic cell which is able to express a desired gene when the cell is present within the individual. The invention also includes compounds which are produced by such cells, or by transkaryotic animals as a reaction to these cells, and the uses of such compounds. <IMAGE>
DK198905447A1987-05-011989-11-01Use of cells for producing an implant for use in gene therapy, a process for producing the implant and a non- human transkaryotic animal containing the implant
DK173137B1
(en)
Use of cells for producing an implant for use in gene therapy, a process for producing the implant and a non- human transkaryotic animal containing the implant
Human manganese superoxide dismutase(hmn-sod),its preparation by genetic engineering,dna sequences coding therefor,vectors containing these dna sequences and host cells which can express them and pharmaceutical compositions containing said enzyme
Process for production of insecticides and acaricides containing pirasoline-derivatives as active substance and process for production of the active substances
PROCESS FOR THE TRANSFORMATION OF CELLS, ESPECIALLY EUKARYOTES, BY CIRCULAR DNA SUCH AS THAT OF HEPATITIS B VIRUS AND PREPARATIONS CONTAINING THE EXPRESSION PRODUCTS OF SAID DNA